Physician profile
Brandy Hood
NPI 1639515786
$9,934.12
in general payments reported to CMS, 2019-2025
46 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,235 · 2020: $960 · 2021: $917 · 2022: $1,491 · 2023: $3,251 · 2024: $964 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,524 · Travel and Lodging: $1,808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,523.51 |
| Travel and Lodging | $1,808.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $3,211.68 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $989.54 | 2019-2020 | |
| Astellas Pharma US INC | $961.15 | 2019-2023 | Myrbetriq |
| Coloplast Corp | $905.01 | 2019-2024 | Coloplast Tfl Drive, Porges Coloplast |
| Myovant Sciences INC. | $404.20 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $396.78 | 2023-2024 | Gemtesa, Myfembree, Orgovyx |
| Laborie Medical Technologies Corp. | $319.86 | 2019-2024 | Urgent PC Neuromodulation System |
| Medtronic, INC. | $227.62 | 2021-2023 | Interstim |
| Urovant Sciences INC | $211.80 | 2021-2022 | |
| Allergan, INC. | $186.12 | 2019-2022 | |
| Medtronic USA, INC. | $158.18 | 2019-2020 | |
| Agiliti Health, INC. | $158.07 | 2023 | Sonablate, Versapulse Powersuite 80w, Soltive |
| Ferring Pharmaceuticals INC. | $138.09 | 2019-2020 | |
| Calyxo, INC. | $131.00 | 2024 | Cvac Aspiration System |
| Abbvie INC. | $126.64 | 2021-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.